Dr. Olivier-Van Stichelen received her PhD in Biochemistry from the University of Lille, France in 2012, where she studied the nutrient-sensing O-GlcNAcylation in colorectal cancer development. After completing her degree, she was appointed as a post-doctoral Fellow at the National Institute of Health, Bethesda, MD, USA. In this lab, Dr. Olivier-Van Stichelen worked on different aspects of O-GlcNAcylation during development, including X-inactivation of the O-GlcNAc Transferase gene, brain O-GlcNAcase function in mouse KO models and the impact of sugar and artificial sweeteners consumption during pregnancy on the development of metabolic homeostasis.

Dr. Olivier-Van Stichelen established her lab at the Medical College of Wisconsin in 2019 at the crossroad of sweeteners, pregnancy, development, and metabolism. Notably, her lab has developed several mouse models for studying O-GlcNAcylation and created the O-GlcNAc database, the reference catalog of O-GlcNAcylated proteins for all species. Some of the current lab projects include studies of (i) O-GlcNAcylation in the pathophysiology of the pituitary gland, (ii) O-GlcNAc transferase’s function in the sexual dimorphism of Gestational Diabetes, and (iii) artificial sweeteners’ impact on detoxification transporters.